temoporfin has been researched along with Mesothelioma in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (38.89) | 18.2507 |
2000's | 11 (61.11) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altermatt, HJ; Krueger, T; Magnusson, L; Mettler, D; Ris, HB; Scholl, B | 1 |
Baas, P; Cramers, P; Dalesio, O; Oppelaar, H; Ruevekamp, M; Stewart, FA | 1 |
Buyske, J; Friedberg, JS; Glatstein, E; Hahn, SM; Metz, J; Mick, R; Pass, HI; Sterman, DH; Stevenson, J; Zhu, T | 1 |
Busch, TM; Friedberg, JS; Glatstein, E; Hahn, SM; Smith, D; Wileyto, EP; Yom, SS | 1 |
Baas, P; Schouwink, H | 1 |
Altermatt, HJ; Krueger, T; Opitz, I; Pan, Y; Ris, HB; Tran, N | 1 |
Altermatt, HJ; Krueger, T; Opitz, I; Pan, Y; Ris, HB; Wagnières, G | 1 |
Altermatt, HJ; Andrejevic-Blant, S; Ballini, JP; Borle, F; Cheng, C; Krueger, T; Pan, Y; Ris, HB; Tran, N; Yan, H | 1 |
Cheng, C; Krueger, T; Michod, D; Petermann, D; Pittet, O; Ris, HB; Widmann, C | 1 |
Altermatt, HJ; Althaus, U; Bonnett, R; Lim, CK; Ris, HB; Schaffner, T; Stewart, CM; Wang, Q | 1 |
Altermatt, HJ; Althaus, U; Bonnett, R; Lim, CK; Nachbur, B; Ris, HB; Stewart, CM; Wang, Q | 1 |
Baas, P; Murrer, L; Peterse, JL; Ris, HB; Rutgers, EJ; Stewart, FA; van Zandwijk, N; Zoetmulder, FA | 1 |
Altermatt, HJ; Althaus, U; Giger, A; Hof, VI; Mettler, D; Ris, HB; Stewart, JC | 1 |
Altermatt, HJ; Althaus, U; Krueger, T; Li, Q; Lim, CK; Reynolds, B; Ris, HB | 1 |
Altermatt, HJ; Althaus, U; Giger, A; Krueger, T; Lim, CK; Ris, HB; Stewart, JC | 1 |
Baas, P; Oppelaar, H; Ruevekamp, M; Schouwink, H; Stewart, FA; van Veen, R | 1 |
Baas, P; Burgers, S; Oppelaar, H; Rutgers, ET; Schouwink, H; Stewart, FA; van der Sijp, J; van Veen, R; van Zandwijk, N; Zoetmulder, F | 1 |
Altermatt, HJ; Berenbaum, MC; Bonnett, R; Hess, R; Inderbitzi, R; Lim, CK; Nachbur, B; Ris, HB; Stewart, JC; Wang, Q | 1 |
4 trial(s) available for temoporfin and Mesothelioma
Article | Year |
---|---|
A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma.
Topics: Aged; Capillary Leak Syndrome; Cause of Death; Chemotherapy, Adjuvant; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hematoporphyrin Photoradiation; Humans; Intraoperative Period; Male; Maximum Tolerated Dose; Mesoporphyrins; Mesothelioma; Middle Aged; Neoplasm Staging; Pleura; Pleural Neoplasms; Pneumonectomy; Postoperative Complications | 2003 |
Elevated serum cytokine levels in mesothelioma patients who have undergone pleurectomy or extrapleural pneumonectomy and adjuvant intraoperative photodynamic therapy.
Topics: Adult; Aged; Cytokines; Female; Humans; Intraoperative Care; Male; Mesoporphyrins; Mesothelioma; Middle Aged; Photochemotherapy; Pleural Cavity; Pleural Effusion, Malignant; Pneumonectomy | 2003 |
Intraoperative photodynamic therapy with m-tetrahydroxyphenylchlorin for chest malignancies.
Topics: Antineoplastic Agents; Brachial Plexus; Combined Modality Therapy; Dose-Response Relationship, Drug; Feasibility Studies; Humans; Infarction; Intraoperative Care; Mesoporphyrins; Mesothelioma; Necrosis; Neoplasm Invasiveness; Peripheral Nervous System Neoplasms; Photochemotherapy; Radiation-Sensitizing Agents; Skin; Thoracic Neoplasms; Thoracotomy; Thrombosis | 1996 |
Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies.
Topics: Adult; Combined Modality Therapy; Dose-Response Relationship, Radiation; Female; Humans; Male; Mesoporphyrins; Mesothelioma; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pleural Neoplasms | 1997 |
14 other study(ies) available for temoporfin and Mesothelioma
Article | Year |
---|---|
Experimental photodynamic therapy for malignant pleural mesothelioma with pegylated mTHPC.
Topics: Animals; Computer Systems; Disease Models, Animal; Female; Mesoporphyrins; Mesothelioma; Mice; Mice, Nude; Photochemotherapy; Photosensitizing Agents; Pleural Neoplasms; Pneumonectomy; Polyethylene Glycols; Radiometry | 2003 |
Foscan uptake and tissue distribution in relation to photodynamic efficacy.
Topics: Animals; Carbon Isotopes; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Light; Mesoporphyrins; Mesothelioma; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Photochemotherapy; Photosensitizing Agents; Tissue Distribution | 2003 |
Foscan-mediated photodynamic therapy and operation for malignant pleural mesothelioma.
Topics: Capillary Leak Syndrome; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Drug Administration Schedule; Humans; Mesoporphyrins; Mesothelioma; Photochemotherapy; Photosensitizing Agents; Pleural Neoplasms; Pneumonectomy; Postoperative Complications; Survival Analysis | 2004 |
Intraoperative photodynamic therapy of the chest cavity in malignant pleural mesothelioma bearing rats.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Combined Modality Therapy; Intraoperative Period; Male; Mesoporphyrins; Mesothelioma; Neoplasm Transplantation; Photochemotherapy; Photosensitizing Agents; Pleural Neoplasms; Pneumonectomy; Rats; Rats, Inbred F344 | 2005 |
Preclinical comparison of mTHPC and verteporfin for intracavitary photodynamic therapy of malignant pleural mesothelioma.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Mesoporphyrins; Mesothelioma; Mice; Necrosis; Photochemotherapy; Photosensitizing Agents; Pleural Neoplasms; Porphyrins; Rats; Rats, Inbred F344; Survival Rate; Verteporfin | 2006 |
Correlation of photodynamic activity and fluorescence signaling for free and pegylated mTHPC in mesothelioma xenografts.
Topics: Animals; Female; Mesoporphyrins; Mesothelioma; Mice; Mice, Nude; Microscopy, Fluorescence; Necrosis; Neoplasm Transplantation; Photochemotherapy; Photosensitizing Agents; Pleural Neoplasms; Transplantation, Heterologous | 2007 |
Effect of the TAT-RasGAP(317-326) peptide on apoptosis of human malignant mesothelioma cells and fibroblasts exposed to meso-tetra-hydroxyphenyl-chlorin and light.
Topics: Apoptosis; Cell Survival; Fibroblasts; GTPase-Activating Proteins; Humans; Mesoporphyrins; Mesothelioma; Peptide Fragments; Peptides; Photochemotherapy; Photosensitizing Agents; Tumor Cells, Cultured | 2007 |
Photodynamic therapy with m-tetrahydroxyphenylchlorin in vivo: optimization of the therapeutic index.
Topics: Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Male; Mesoporphyrins; Mesothelioma; Mice; Mice, Inbred BALB C; Mice, Nude; Photochemotherapy; Radiation-Sensitizing Agents; Temperature | 1993 |
Experimental assessment of photodynamic therapy with chlorins for malignant mesothelioma.
Topics: Animals; Antineoplastic Agents; Humans; Mesoporphyrins; Mesothelioma; Mice; Mice, Nude; Neoplasm Transplantation; Photochemotherapy; Photosensitizing Agents; Pleural Neoplasms; Polyethylene Glycols; Swine; Swine, Miniature; Transplantation, Heterologous | 1997 |
Photosensitizing effects of m-tetrahydroxyphenylchlorin on human tumor xenografts: correlation with sensitizer uptake, tumor doubling time and tumor histology.
Topics: Adenocarcinoma; Animals; Carcinoma, Squamous Cell; Female; Humans; Mesoporphyrins; Mesothelioma; Mice; Mice, Nude; Necrosis; Neoplasm Transplantation; Neoplasms, Experimental; Photochemotherapy; Photosensitizing Agents; Transplantation, Heterologous | 1998 |
Photodynamic therapy with mTHPC and polyethylene glycol-derived mTHPC: a comparative study on human tumour xenografts.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Dermatitis, Phototoxic; Humans; Mesoporphyrins; Mesothelioma; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Photochemotherapy; Polyethylene Glycols; Radiation-Sensitizing Agents; Transplantation, Heterologous | 1999 |
Photodynamic therapy for malignant mesothelioma: preclinical studies for optimization of treatment protocols.
Topics: Animals; Carbon Dioxide; Combined Modality Therapy; Disease Models, Animal; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Humans; Mesoporphyrins; Mesothelioma; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Niacinamide; Oxygen; Photochemotherapy; Photosensitizing Agents | 2001 |
Intraoperative photodynamic therapy after pleuropneumonectomy in patients with malignant pleural mesothelioma: dose finding and toxicity results.
Topics: Adult; Aged; Chemotherapy, Adjuvant; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Intraoperative Care; Male; Mesoporphyrins; Mesothelioma; Middle Aged; Neoplasm Staging; Photochemotherapy; Pleural Neoplasms; Pneumonectomy | 2001 |
Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results.
Topics: Combined Modality Therapy; Evaluation Studies as Topic; Humans; Male; Mesoporphyrins; Mesothelioma; Middle Aged; Photochemotherapy; Radiation-Sensitizing Agents | 1991 |